Be on Top of the Latest Happenings: Complementary Research on Novogen, Bio-Rad, ZS Pharma, T2 Biosystems and Vertex Energy
NEW YORK, May 11, 2015 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Moments ago, Analysts Review released new research updates concerning several important developing situations including Novogen Limited (NASDAQ: NVGN), Bio-Rad Laboratories, Inc. (NASDAQ: BIO), ZS Pharma, Inc. (NASDAQ: ZSPH), T2 Biosystems, Inc. (NASDAQ: TTOO), and Vertex Energy, Inc. (NASDAQ: VTNR). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
To access our full PDF reports on a complementary basis, please visit the links below.
--
Today's update concerns the following companies:
============
Full PDF Download Links (you may have to copy and paste the following links into your browser):
NVGN Research Report: ( http://get.analystsreview.com/pdf/?c=Novogen&d=11-May-2015&s=NVGN ),
BIO Research Report: ( http://get.analystsreview.com/pdf/?c=Bio-Rad&d=11-May-2015&s=BIO ),
ZSPH Research Report: ( http://get.analystsreview.com/pdf/?c=ZS%20Pharma&d=11-May-2015&s=ZSPH ),
TTOO Research Report: ( http://get.analystsreview.com/pdf/?c=T2%20Biosystems&d=11-May-2015&s=TTOO ),
VTNR Research Report: ( http://get.analystsreview.com/pdf/?c=Vertex%20Energy&d=11-May-2015&s=VTNR ).
============
--
Analyst Update: Financial Results, Appointments and Operational Updates
U.S. stocks advanced sharply on Friday, after stronger employment data for April suggested the US economy is gaining traction again. The Dow Jones Industrial Average rose 1.49%, to close at 18,191.11, the S&P 500 gained 1.35%, to 2,116.10, and the NASDAQ Composite finished the session at 5,003.55, up 1.17%. European stocks rallied on Friday, lifted by the UK election results, which showed the Conservative Party unexpectedly sweeping into power again. Germany's DAX 30 rose 2.65%, France's CAC 40 advanced 2.48%, and the London's FTSE 100 closed 2.32% higher on Friday. Meanwhile, Asian markets surged on Friday after losing ground in the last few days. The Shanghai Composite, Japan's Nikkei, and Hong Kong's Hang Seng all posted gains on Friday.
On April 29, 2015, Novogen Limited announced that it has completed the placement of 51,750,000 ordinary shares to US Institutional Investors as the Company had previously announced to the market on April 21, 2015, thereby raising a total of $15,525,000 before costs.
Bio-Rad Laboratories, Inc. announced its financial results for the first quarter on May 5, 2015. The Company reported first quarter gross margin of 57.1% versus reported figures of 54.0% in the previous year quarter.
ZS Pharma, Inc. announced on May 5, 2015 the appointment of Ms. Kimberly J. Popovits to the Company's Board of Directors. Ms. Popovits, presently the Chairman of the Board, Chief Executive Officer and President of Genomic Health, holds over three decades of experience in the life sciences industry having held various commercialization and leadership roles in the healthcare industry.
Bloomberg report that on May 5, 2015, T2 Biosystems, Inc. announced its operating highlights for the first quarter of 2015. As per Bloomberg, the Company secured two customer contracts and one completed installation for the T2Candida® Panel and T2Dx® Instrument.
According to a report by Bloomberg dated May 6, 2015, Vertex Energy, Inc. announced that its wholly owned subsidiary, Vertex Refining NV, LLC, has leased a re-refinery plant located in Churchill County, Nevada.
--
About Analysts Review
At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.
--
Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.
Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider, represented by a registered analyst has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article